X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Researchers Push For Antibiotic Nod In Brazil, India, And SA

    Serum Institute Wins USFDA Nod To Export Novavax COVID Jab

    Serum Institute Wins USFDA Nod To Export Novavax COVID Jab

    Pfizer, Moderna & AstraZeneca - Their COVID-19 vaccine comparison

    The Fourth COVID-19 Vaccine Reduces Senior Mortality By 72%

    NIH Initiates Clinical Study of mRNA Nipah Virus Vaccine

    NIH Initiates Clinical Study of mRNA Nipah Virus Vaccine

    As Medical Uses Cope Up, Genomic Studies Reap Scale Benefits

    As Medical Uses Cope Up, Genomic Studies Reap Scale Benefits

    Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations

    FDA Clears Novavax COVID-19 Vaccine As Fourth Option In US

    Australia Creates A Novel Stem Cell Production Technique

    Australia Creates A Novel Stem Cell Production Technique

    U.S. Officials Clear COVID-19 Jab For Infants, Preschoolers

    U.S. Officials Clear COVID-19 Jab For Infants, Preschoolers

    Bispecific Blood Cancer Drug By Roche Globally Approved

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Researchers Push For Antibiotic Nod In Brazil, India, And SA

    Serum Institute Wins USFDA Nod To Export Novavax COVID Jab

    Serum Institute Wins USFDA Nod To Export Novavax COVID Jab

    Pfizer, Moderna & AstraZeneca - Their COVID-19 vaccine comparison

    The Fourth COVID-19 Vaccine Reduces Senior Mortality By 72%

    NIH Initiates Clinical Study of mRNA Nipah Virus Vaccine

    NIH Initiates Clinical Study of mRNA Nipah Virus Vaccine

    As Medical Uses Cope Up, Genomic Studies Reap Scale Benefits

    As Medical Uses Cope Up, Genomic Studies Reap Scale Benefits

    Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations

    FDA Clears Novavax COVID-19 Vaccine As Fourth Option In US

    Australia Creates A Novel Stem Cell Production Technique

    Australia Creates A Novel Stem Cell Production Technique

    U.S. Officials Clear COVID-19 Jab For Infants, Preschoolers

    U.S. Officials Clear COVID-19 Jab For Infants, Preschoolers

    Bispecific Blood Cancer Drug By Roche Globally Approved

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development FDA Approvals

Serum Institute Wins USFDA Nod To Export Novavax COVID Jab

Content Team by Content Team
19th July 2022
in FDA Approvals, News
Serum Institute Wins USFDA Nod To Export Novavax COVID Jab

The FDA has given the go-ahead to the Serum Institute of India (SII) to eventually supply a COVID-19 vaccine to the U.S. with Novavax’s Nuvaxovid.

The emergency use authorization granted to Novavax’s recombinant protein-based vaccination on July 13th means SII will be able to distribute the shot, also known as Covovax, to the United States from India.

The adenovirus-vectored vaccination Vaxzevria, manufactured by SII for AstraZeneca, is not offered in the United States. With the approval of Novavax, SII is officially the first Indian pharmaceutical company to create a COVID injectable for the American market.

According to Novavax Chief Medical Officer Filip Dubovsky, SII produces all of the commercially available Novavax shots, including those that are initially used in the United States.

Following a favourable recommendation from an FDA expert panel, the U.S. government obtained an inaugural 3.2 million doses of the Novavax shot. A leading media daily was previously informed by a Novavax representative that some dosages had already arrived on July 6.

Prior to the 13th July approval, there were rumours that Novavax had trouble meeting production criteria, particularly those pertaining to vaccine purity.

The late debut of Novavax and SII coincides with a decline in the market for COVID vaccinations worldwide. Adar Poonawalla, CEO of SII, reportedly stated that the company has discontinued producing AstraZeneca’s shot after accumulating 200 million doses because it was unable to find any buyers, even for free.

One of the leading newspapers revealed this week, using data from the CDC, that around 90.6 million shots of various COVID vaccination doses have been disposed of in the United States. The Vaccine Alliance and Novavax entered an advance purchase agreement last May to provide up to 350 million shots of Nuvaxovid for mass distribution in low-income nations. These were a part of an arrangement that covered a total of 1.1 billion doses of the shot, with SII taking care of the remaining supply.

As a potential booster, Novavax and SII are developing an improved omicron-targeted injection. In Australia, Novavax began a phase 3 study for the omicron-specific vaccine, coded NVX-CoV2515, in late May. Participants in the experiment had previously received either a core series of an mRNA vaccine or a booster series.

Previous Post

The US Has Prolonged The COVID-19 Public Health Emergency

Next Post

India Administers 2bn COVID-19 Jabs, Cases At 4 Month-High

Related Posts

FDA Approvals

Researchers Push For Antibiotic Nod In Brazil, India, And SA

19th July 2022
India Administers 2bn COVID-19 Jabs, Cases At 4 Month-High
Health & Nutrition

India Administers 2bn COVID-19 Jabs, Cases At 4 Month-High

19th July 2022
T2 Biosystems T2SARS-CoV-2 Panel Detects Omicron Subvariants
News

The US Has Prolonged The COVID-19 Public Health Emergency

18th July 2022
Pfizer, Moderna & AstraZeneca - Their COVID-19 vaccine comparison
News

The Fourth COVID-19 Vaccine Reduces Senior Mortality By 72%

18th July 2022
NIH Initiates Clinical Study of mRNA Nipah Virus Vaccine
Clinical Trials

NIH Initiates Clinical Study of mRNA Nipah Virus Vaccine

18th July 2022
Could The Long Deckline In Biotechnology M&A Be Ending
Featured

Could The Long Deckline In Biotechnology M&A Be Ending

16th July 2022
Next Post
India Administers 2bn COVID-19 Jabs, Cases At 4 Month-High

India Administers 2bn COVID-19 Jabs, Cases At 4 Month-High

Latest News

FDA Approvals

Researchers Push For Antibiotic Nod In Brazil, India, And SA

19th July 2022
India Administers 2bn COVID-19 Jabs, Cases At 4 Month-High
Health & Nutrition

India Administers 2bn COVID-19 Jabs, Cases At 4 Month-High

19th July 2022
Serum Institute Wins USFDA Nod To Export Novavax COVID Jab
FDA Approvals

Serum Institute Wins USFDA Nod To Export Novavax COVID Jab

19th July 2022
T2 Biosystems T2SARS-CoV-2 Panel Detects Omicron Subvariants
News

The US Has Prolonged The COVID-19 Public Health Emergency

18th July 2022
Pfizer, Moderna & AstraZeneca - Their COVID-19 vaccine comparison
News

The Fourth COVID-19 Vaccine Reduces Senior Mortality By 72%

18th July 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In